A detailed history of Black Rock Inc. transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 17,070,422 shares of CTKB stock, worth $88.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,070,422
Previous 17,425,971 2.04%
Holding current value
$88.8 Million
Previous $117 Million 18.54%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$5.3 - $6.91 $1.88 Million - $2.46 Million
-355,549 Reduced 2.04%
17,070,422 $95.3 Million
Q1 2024

May 10, 2024

SELL
$6.29 - $9.15 $2.23 Million - $3.24 Million
-353,782 Reduced 1.99%
17,425,971 $117 Million
Q4 2023

Feb 13, 2024

BUY
$4.1 - $9.51 $4.14 Million - $9.6 Million
1,009,080 Added 6.02%
17,779,753 $162 Million
Q3 2023

Nov 13, 2023

BUY
$5.52 - $9.5 $9.07 Million - $15.6 Million
1,643,168 Added 10.86%
16,770,673 $92.6 Million
Q2 2023

Aug 11, 2023

BUY
$6.69 - $11.99 $45.8 Million - $82 Million
6,840,258 Added 82.54%
15,127,505 $129 Million
Q1 2023

May 12, 2023

SELL
$8.44 - $13.47 $678,238 - $1.08 Million
-80,360 Reduced 0.96%
8,287,247 $76.2 Million
Q4 2022

Feb 13, 2023

BUY
$9.71 - $15.86 $4.37 Million - $7.14 Million
449,965 Added 5.68%
8,367,607 $85.4 Million
Q3 2022

Nov 14, 2022

BUY
$10.96 - $15.45 $8.55 Million - $12.1 Million
780,250 Added 10.93%
7,917,642 $117 Million
Q2 2022

Aug 12, 2022

BUY
$7.41 - $11.56 $7.74 Million - $12.1 Million
1,044,052 Added 17.13%
7,137,392 $76.6 Million
Q1 2022

May 12, 2022

BUY
$9.89 - $17.25 $36.8 Million - $64.2 Million
3,722,881 Added 157.05%
6,093,340 $65.7 Million
Q4 2021

Feb 10, 2022

BUY
$16.14 - $25.04 $8.32 Million - $12.9 Million
515,716 Added 27.81%
2,370,459 $38.7 Million
Q3 2021

Nov 09, 2021

BUY
$17.52 - $27.93 $32.5 Million - $51.8 Million
1,854,743 New
1,854,743 $39.7 Million

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $700M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.